IBD NORTHERN LTS FD TR IV

Ownership history in LVZ, Inc.  ·  33 quarters on record

This page tracks every 13F SEC filing in which LVZ, Inc. reported a position in NORTHERN LTS FD TR IV (IBD). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.59% (2023 Q3)
Avg. % of fund
0.35%
First filed
2017 Q4
Last filed
2025 Q4
Quarters held
33
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 REDUCED 182,015 -1,086 -0.6% 0.49% $4.4M $24.06
2025 Q3 ADDED 183,101 +3,131 +1.7% 0.50% $4.4M $23.74
2025 Q2 REDUCED 179,970 -7,434 -4.0% 0.52% $4.3M $23.36
2025 Q1 ADDED 187,404 +2,011 +1.1% 0.58% $4.5M $22.85
2024 Q4 ADDED 185,393 +14,676 +8.6% 0.56% $4.3M $22.34
2024 Q3 REDUCED 170,717 -737 -0.4% 0.53% $4.1M $22.68
2024 Q2 REDUCED 171,454 -3,271 -1.9% 0.55% $4.0M $21.73
2024 Q1 ADDED 174,725 +8,015 +4.8% 0.56% $4.1M $21.66
2023 Q4 ADDED 166,710 +4,168 +2.6% 0.56% $3.9M $21.57
2023 Q3 ADDED 162,542 +1,554 +1.0% 0.59% $3.7M $20.46
23 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    IBD price (monthly, adj. close)
← Back to LVZ, Inc. Holdings